Location History:
- Kyungki-do, KR (1997)
- Seoul, KR (1996 - 2019)
- Gyeonggi-do, KR (2003 - 2020)
Company Filing History:
Years Active: 1996-2020
Title: Innovations in Cancer Treatment by Jin-Soo Lee
Introduction
Jin-Soo Lee, a prolific inventor based in Seoul, South Korea, has significantly contributed to the field of cancer treatment with a remarkable portfolio of 18 patents. His innovative methods focus on isolating and proliferating autologous cancer antigen-specific CD8T cells, offering promising advancements in personalized medicine.
Latest Patents
Among his latest innovations, Jin-Soo Lee developed methods for isolating and proliferating autologous cancer antigen-specific CD8T cells. This involves selecting an epitope recognized by CD8T cells from autologous cancer antigens found in the blood of individual cancer patients. His approach allows for the isolation of these specific T cells using a peptide derived from the selected epitope. By utilizing T cells that recognize the patient's own cancer antigens, the method aims to effectively target and eliminate cancer cells without causing adverse side effects commonly associated with traditional treatments.
Career Highlights
Jin-Soo Lee has an impressive career, having worked with prominent companies such as LG Electronics Inc. and Samsung Electronics Co., Ltd. His experiences in these leading firms have likely contributed to his deep understanding of innovative technologies and their applications in healthcare.
Collaborations
Throughout his career, Jin-Soo Lee has collaborated with talented professionals, including coworkers Hyeon-June Kim and Hyeon-Jun Kim. These partnerships have enriched his research endeavors and facilitated advancements in his patented methodologies.
Conclusion
Jin-Soo Lee’s contributions to cancer treatment through his innovative patents highlight the vital intersection of technology and medicine. His research not only paves the way for more effective cancer therapies but also sets a precedent for future innovations in the medical field. As he continues to advance the understanding of autologous cancer treatments, the medical community eagerly awaits further developments from this influential inventor.